Cargando…

Comparison of the measurement properties of the EQ-5D-5L and SF-6Dv2 among overweight and obesity populations in China

OBJECTIVE: To evaluate and compare the measurement properties of the EQ-5D-5L and SF-6Dv2 among Chinese overweight and obesity populations. METHODS: A representative sample of Chinese overweight and obesity populations was recruited stratified by age, gender, body mass index (BMI), and area of resid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Shitong, Li, Meixuan, Wang, Dingyao, Hong, Tianqi, Guo, Weihua, Wu, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617156/ https://www.ncbi.nlm.nih.gov/pubmed/37904216 http://dx.doi.org/10.1186/s12955-023-02202-1

Ejemplares similares

Comparison of the measurement properties of SF-6Dv2 and EQ-5D-5L in a Chinese population health survey
por: Xie, Shitong, et al.
Publicado: (2022)

Psychometric performance of EQ-5D-5L and SF-6DV2 in measuring health status of populations in Chinese university staff and students
por: Zhou, Hui Jun, et al.
Publicado: (2023)

EQ-5D-5L and SF-6Dv2 utility scores in people living with chronic low back pain: a survey from Quebec
por: Poder, Thomas G, et al.
Publicado: (2020)

Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D
por: Shiroiwa, Takeru, et al.
Publicado: (2015)

Comparison of the psychometric properties of the EQ-5D-3L and SF-6D in the general population of Chengdu city in China
por: Zhao, Longchao, et al.
Publicado: (2019)

Valuation of SF-6Dv2 Health States in China Using Time Trade-off and Discrete-Choice Experiment with a Duration Dimension
por: Wu, Jing, et al.
Publicado: (2021)

Discriminative validity of the EQ-5D-5 L and SF-12 in older adults with arthritis
por: Tawiah, Andrews K., et al.
Publicado: (2019)

Comparison between EQ-5D and SF-6D Utility in Rural Residents of Jiangsu Province, China
por: Jin, Hui, et al.
Publicado: (2012)

Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease
por: van Stel, Henk F, et al.
Publicado: (2006)

Comparison of SF-6D and EQ-5D Scores in Patients With Breast Cancer
por: Yousefi, Mahmood, et al.
Publicado: (2016)

Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients
por: Pattanaphesaj, Juntana, et al.
Publicado: (2015)

Psychometric properties of the EQ-5D-5L compared with EQ-5D-3L in cancer patients in Iran
por: Moradi, Nasrin, et al.
Publicado: (2022)

Development of the SF-6Dv2 health utility survey: comprehensibility and patient preference
por: Broderick, Lynne, et al.
Publicado: (2022)

A Comparison of EQ-5D-3L, EQ-5D-5L, and SF-6D Utilities of Patients with Musculoskeletal Disorders of Different Severity: A Health-Related Quality of Life Approach
por: Kontodimopoulos, Nikolaos, et al.
Publicado: (2022)

A head-to-head comparison of EQ-5D-5 L and SF-6D in Chinese patients with low back pain
por: Ye, Ziping, et al.
Publicado: (2019)

Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients
por: Golicki, Dominik, et al.
Publicado: (2014)

Comparing measurement properties of EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients
por: Fitriana, Titi Sahidah, et al.
Publicado: (2021)

A Comparison of the SF-6Dv2 and SF-6D UK Utility Values in a Mixed Patient and Healthy Population
por: McDool, Emily, et al.
Publicado: (2021)

The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis
por: Harrison, M. J., et al.
Publicado: (2009)

Mapping the Positive and Negative Syndrome Scale scores to EQ-5D-5L and SF-6D utility scores in patients with schizophrenia
por: Abdin, Edimansyah, et al.
Publicado: (2018)

Population norms for the EQ-5D-3L and EQ-5D-5L in Romania
por: Olariu, Elena, et al.
Publicado: (2023)

Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L descriptive systems and utilities in atopic dermatitis
por: Koszorú, Kamilla, et al.
Publicado: (2022)

Estimating the disutility of relapse in relapsing–remitting and secondary progressive multiple sclerosis using the EQ-5D-5L, AQoL-8D, EQ-5D-5L-psychosocial, and SF-6D: implications for health economic evaluation models
por: Ahmad, Hasnat, et al.
Publicado: (2023)

Correction to: A Comparison of the SF-6Dv2 and SF-6D UK Utility Values in a Mixed Patient and Healthy Population
por: McDool, Emily, et al.
Publicado: (2021)

Comparing the psychometric properties of EQ-5D-3L and EQ-5D-5L proxy ratings by informal caregivers and a health professional for people with dementia
por: Michalowsky, Bernhard, et al.
Publicado: (2022)

Level of agreement between patient-reported EQ-5D responses and EQ-5D responses mapped from the SF-12 in an injury population
por: Gabbe, Belinda J, et al.
Publicado: (2015)

Mapping SF-36 onto the EQ-5D index: how reliable is the relationship?
por: Rowen, Donna, et al.
Publicado: (2009)

Assessment of Quality of Life in Patients With Cardiovascular Disease Using the SF-36, MacNew, and EQ-5D-5L Questionnaires
por: Chatzinikolaou, Aikaterini, et al.
Publicado: (2021)

Estimation of minimally important differences in the EQ-5D and SF-6D indices and their utility in stroke
por: Kim, Sang-Kyu, et al.
Publicado: (2015)

Mapping the PHQ-8 to EQ-5D, HUI3 and SF6D in patients with depression
por: Abdin, Edimansyah, et al.
Publicado: (2021)

EQ-5D-5L norms for the urban Chinese population in China
por: Yang, Zhihao, et al.
Publicado: (2018)

An empirical evaluation of the SF-12, SF-6D, EQ-5D and Michigan Hand Outcome Questionnaire in patients with rheumatoid arthritis of the hand
por: Dritsaki, Melina, et al.
Publicado: (2017)

Comparing the performance of the EQ-5D-3L and the EQ-5D-5L in young Portuguese adults
por: Ferreira, Lara N., et al.
Publicado: (2016)

Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets
por: Mulhern, Brendan, et al.
Publicado: (2018)

Head-to-Head Comparison of EQ‐5D‐3L and EQ‐5D‐5L Health Values
por: Selivanova, Anna, et al.
Publicado: (2018)

Comparing the performance of the EQ-5D-3 L and the EQ-5D-5 L in an elderly Chinese population
por: You, Ruxu, et al.
Publicado: (2020)

EQ-5D-5L measurement properties are superior to EQ-5D-3L across the continuum of health using US value sets
por: Jiang, Ruixuan, et al.
Publicado: (2022)

Validation and comparison of EuroQoL-5 dimension (EQ-5D) and Short Form-6 dimension (SF-6D) among stable angina patients
por: Wu, Jing, et al.
Publicado: (2014)

Comparing the performance of the EQ-5D and SF-6D when measuring the benefits of alleviating knee pain
por: Barton, Garry R, et al.
Publicado: (2009)

Mapping the FACT-G cancer-specific quality of life instrument to the EQ-5D and SF-6D
por: Teckle, Paulos, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hoqvqv5idctk6judh3209697kt